Jentzsch, M., Bill, M., Grimm, J., Schulz, J., Schuhmann, L., Brauer, D., . . . Schwind, S. (2020). High expression of the stem cell marker <i>GPR56</i> at diagnosis identifies acute myeloid leukemia patients at higher relapse risk after allogeneic stem cell transplantation in context with the CD34+/CD38- population. Ferrata Storti Foundation.
Chicago-čujuhus (17. p.)Jentzsch, Madlen, et al. High Expression of the Stem Cell Marker <i>GPR56</i> at Diagnosis Identifies Acute Myeloid Leukemia Patients at Higher Relapse Risk After Allogeneic Stem Cell Transplantation in Context with the CD34+/CD38- Population. Ferrata Storti Foundation, 2020.
MLA-čujuhus (9. p.)Jentzsch, Madlen, et al. High Expression of the Stem Cell Marker <i>GPR56</i> at Diagnosis Identifies Acute Myeloid Leukemia Patients at Higher Relapse Risk After Allogeneic Stem Cell Transplantation in Context with the CD34+/CD38- Population. Ferrata Storti Foundation, 2020.